AlphaMark Advisors, LLC
- SEC CIK
- 0001348183
- Latest filing
- Jan 21, 2025
CTMX holding history
CytomX Therapeutics, Inc. in every 13F filed by AlphaMark Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
CTMX overviewAll 13F holders of CTMXFull Q4 2024 holdings
- Shares (Q1 2024)
- 0
- Sold out in Q1 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 7
- Since Q1 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2024 | 0 | $0 | 0.0% | −23,183−100.0% | Sold out | Holders |
| Q4 2023 | 23,183 | $36.0K | <0.1% | +12,635+119.8% | Added | Holders |
| Q3 2023 | 10,548 | $14.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 10,548 | $18.0K | <0.1% | +6,015+132.7% | Added | Holders |
| Q1 2023 | 4,533 | $7.00K | <0.1% | +4,533 | New | Holders |
| Q4 2022 | 0 | $0 | 0.0% | −20,000−100.0% | Sold out | Holders |
| Q3 2022 | 20,000 | $29.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2022 | 20,000 | $37.0K | <0.1% | +17,000+566.7% | Added | Holders |
| Q1 2022 | 3,000 | $8.00K | <0.1% | +3,000 | New | Holders |